C8..
CANCELLED SEC. 8 (6-YR)
08/07/2026
Back to search
Official data from USPTO
NOVAGO PROMOBILITY THERAPEUTICS
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (6-YR)Type: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (6-YR)
Case type
Application and registration
Recorded events
65
Latest update
08/07/2026
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
01/26/2018
Registration date
01/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2026
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Schlieren, CH
Examiner
LAVOIE, RYAN CHRISTOPHER
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "NOVAGO" in green font above the wording "PROMOBILITY THERAPEUTICS" in black font. To the right of the wording is a stylized image comprised of a design of four gray lines
Holders and representatives
Holders
NovaGo Therapeutics AG
Representatives
Janice Housey
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical productsfor the regenerative treatment of disorders affecting human beingsincluding but not limited tocentral nervous systemeyeskin and other disorders; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposesbiological monoclonal antibodies and formulations for human therapeutic use; biological preparations for use in industry and science; peptides for chemical products and foodstuffs in the nature of biological monoclonal antibodies and formulations for human therapeutic use; polypeptides; antibodies and proteins for scientific use
Class 5
Pharmaceutical preparationsfor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; veterinary preparationsfor the regenerative treatment of disordersincludingbut not limited tocentral nervous systemeyeskin and other; preparations for immunotherapeutic purposesfor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; products for the removal of tumorsnamely preparations for neurodegenerative diseasesbut not limited totraumatic brain injuryspinal cord injurystroke; immunogens for medical usefor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; vaccinesantibodiesepitopes for pharmaceutical use; peptides for pharmaceutical purposes; sanitary preparations for medical use for the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; biological preparations for medical use for the treatment of neurologicalophthalmicskin disorders; biocides; diagnostic productsfor the development of new therapeutic agents; towels for hygiene purposessanitary towels; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposesfor the regenerative treatment of disordersincludingbut not limited tocentral nervous systemeyeskin and other disorders
Class 42
Monitoring of degenerative and traumatic disorders affecting human beings for quality control purposes; Research in the field of regenerative treatment of degenerative or traumatic human disorders; medical research in the field of sanitary care; computer software designcomputer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparationspreparations for regenerative treatment of human disorders; software maintenance
Class 44
Medical services; medical services in the field of immunity; provision of medical information; medical examinationsassessments used for clinical research purposes ; dispensing of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance in the nature of veterinary servicesassessments and procedures that leads to novel pharmaceutical products; beauty salon services; care services for animalsnamely for the regenerative treatment of veterinary trauma disorders; hygienic care; consultancy and provision of information relating to the operationpreparationadministration and dosage of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
65 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/28/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/21/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/13/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/13/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/27/2019
GNRT
NON-FINAL ACTION E-MAILED
08/27/2019
CNRT
NON-FINAL ACTION WRITTEN
08/27/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/05/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/16/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
07/03/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/03/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
07/03/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2019
GNRT
NON-FINAL ACTION E-MAILED
07/02/2019
CNRT
NON-FINAL ACTION WRITTEN
07/02/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/10/2019
GPRA
PRIORITY ACTION E-MAILED
01/10/2019
CPRA
PRIORITY ACTION WRITTEN
01/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2018
ALIE
ASSIGNED TO LIE
12/13/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/06/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/29/2018
GNSL
LETTER OF SUSPENSION E-MAILED
11/29/2018
CNSL
SUSPENSION LETTER WRITTEN
11/29/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2018
GNRT
NON-FINAL ACTION E-MAILED
05/14/2018
CNRT
NON-FINAL ACTION WRITTEN
05/14/2018
DOCK
ASSIGNED TO EXAMINER
05/09/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2018
NWAP
NEW APPLICATION ENTERED
01/30/2018
Continuous trademark protection
Get notified about every new filing that threatens NOVAGO PROMOBILITY THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.